High glucose promotes PRDM16 proteolysis and adipose tissue fibrosis
Abstract
Abstract Chronic nutrient excess drives adipose tissue fibrosis and inflammation, key features of metabolic dysfunction that underlie insulin resistance and Type 2 diabetes. However, the molecular mechanisms linking hyperglycemia to pathological adipose tissue remodeling remain less understood. Here, we identify a post-translational mechanism by which high glucose destabilizes PRDM16, a key transcriptional regulator of adipose tissue identity, through O-GlcNAcylation of its E3 ligase adaptor protein, amyloid beta precursor protein binding protein 2 (APPBP2). Glucose-induced O-GlcNAcylation of APPBP2 at S561 promotes its interaction with PRDM16, triggering PRDM16 ubiquitination and proteasomal degradation. Notably, APPBP2S561N is a hypomorphic variant identified in human populations who exhibit improved glucose homeostasis. Knock-in mice harboring APPBP2S561N maintained elevated PRDM16 protein levels independently of mRNA abundance and are protected against diet-induced adipose tissue fibrosis, inflammation, glucose intolerance, and insulin resistance. These metabolic benefits are independent of UCP1-mediated thermogenesis, as metabolic protection of APPBP2S561N persists in the Ucp1 null background. These findings reveal a glucose-responsive O-GlcNAc pathway that couples nutrient excess to adipose tissue dysfunction through post-translational regulation of PRDM16 protein stability.